🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Cliff Asness’s IART Holdings & Trades

First Buy
Q1 2015
Duration Held
41 Quarters
Largest Add
Q2 2023
+397,508 Shares
Current Position
119,471 Shares
$1.48 M Value

Cliff Asness's IART Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 119,471 shares of Integra LifeSciences Holdings Corporation (IART) worth $1.48 M, representing 0.00% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 41 quarters.

Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in IART, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2023, adding 397,508 shares. Largest reduction occurred in Q3 2024, reducing 524,046 shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's Integra LifeSciences Holdings Corporation (IART) Holding Value Over Time

Track share changes against reported price movement

Quarterly Integra LifeSciences Holdings Corporation (IART) Trades by Cliff Asness

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 -11,145 Reduce 8.53% 119,471 $12.42
Q3 2025 +22,658 Add 20.99% 130,616 $13.77
Q2 2025 +45,200 Add 72.02% 107,958 $12.27
Q1 2025 -1,028 Reduce 1.61% 62,758 $21.99
Q4 2024 -23,966 Reduce 27.31% 63,786 $22.68
Q3 2024 -524,046 Reduce 85.66% 87,752 $17.91
Q2 2024 +291,326 Add 90.91% 611,798 $28.50
Q1 2024 -226,731 Reduce 41.43% 320,472 $34.74
Q4 2023 -216,975 Reduce 28.39% 547,203 $43.55
Q3 2023 -50,710 Reduce 6.22% 764,178 $38.19
Q2 2023 +397,508 Add 95.24% 814,888 $41.13
Q1 2023 -10,348 Reduce 2.42% 417,380 $56.99
Q4 2022 -2,550 Reduce 0.59% 427,728 $55.97
Q3 2022 +166,335 Add 63.02% 430,278 $42.36
Q2 2022 +135,062 Add 104.80% 263,943 $54.03
Q1 2022 +43,393 Add 50.76% 128,881 $64.26
Q4 2021 +27,181 Add 46.62% 85,488 $66.99
Q3 2021 -17,135 Reduce 22.71% 58,307 $68.48
Q2 2021 -77,410 Reduce 50.64% 75,442 $68.24
Q1 2021 -55,007 Reduce 26.46% 152,852 $69.08
Q4 2020 -52,248 Reduce 20.09% 207,859 $64.92
Q3 2020 +116,842 Add 81.56% 260,107 $46.55
Q2 2020 +143,265 New Buy 143,265 $46.23
Q1 2020 -99,571 Sold Out 0 $0.00
Q4 2019 +13,822 Add 16.12% 99,571 $58.28
Q3 2019 +73,944 Add 626.38% 85,749 $60.07
Q2 2019 +11,805 New Buy 11,805 $55.82
Q2 2018 -6,961 Sold Out 0 $0.00
Q4 2017 -10,683 Reduce 60.55% 6,961 $47.84
Q3 2017 -1,228 Reduce 6.51% 17,644 $50.50
Q2 2017 -10,044 Reduce 34.74% 18,872 $54.53
Q1 2017 -4,676 Reduce 13.92% 28,916 $42.12
Q4 2016 -1,706 Reduce 4.83% 33,592 $42.90
Q3 2016 +2,984 Add 9.23% 35,298 $41.28
Q2 2016 -2,400 Reduce 6.91% 32,314 $39.89
Q1 2016 -8,390 Reduce 19.46% 34,714 $33.68
Q4 2015 +9,176 Add 27.05% 43,104 $33.89
Q3 2015 +8,008 Add 30.90% 33,928 $29.77
Q2 2015 +14,120 Add 119.66% 25,920 $33.68
Q1 2015 +11,800 New Buy 11,800 $30.85

Cliff Asness's Integra LifeSciences Holdings Corporation Investment FAQs

Cliff Asness first purchased Integra LifeSciences Holdings Corporation (IART) in Q1 2015, acquiring 11,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held Integra LifeSciences Holdings Corporation (IART) for 41 quarters since Q1 2015.

Cliff Asness's largest addition to Integra LifeSciences Holdings Corporation (IART) was in Q2 2023, adding 814,888 shares worth $33.52 M.

According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 119,471 shares of Integra LifeSciences Holdings Corporation (IART), valued at approximately $1.48 M.

As of the Q4 2025 filing, Integra LifeSciences Holdings Corporation (IART) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.

Cliff Asness's peak holding in Integra LifeSciences Holdings Corporation (IART) was 814,888 shares, as reported at the end of Q2 2023.